Birger E Rhenman

Suggest Changes
Learn More
OBJECTIVE Under Food and Drug Administration investigational device exemption, the Prospective Randomized On-X Anticoagulation Clinical Trial (PROACT) has been testing the safety of less aggressive(More)
  • 1